Literature DB >> 23285320

Multiple systemic diseases complicated by bisphosphonate osteonecrosis: a case report.

Fabrizio Carini1, Lorena Barbano, Vito Saggese, Dario Monai, Gianluca Porcaro.   

Abstract

AIMS: this work aims at demonstrating that multiple systemic conditions, in association with the development of bisphosphonate associated osteonecrosis of the jaw (ONJ), increase the risk of complications and may lead to hospitalization. For this reason the dental approach to patients with multisystem disease should be carefully managed by a team of specialists. CASE REPORT: a case of mandibular necrosis associated with intake of oral bisphosphonates in a complex systemic context is described. RESULTS AND DISCUSSION: many different diseases and systemic conditions may draw the line at oral surgery. Multiple treatments (e.g. antithrombotic, calcium channel blockers, diuretics, antibiotics and bisphosphonates) can alter the normal physiological response to tissue healing.
CONCLUSIONS: patients taking bisphosphonates for more than three years (i.e. the term over which the risk of ONJ increases according to the literature, in presence of complex systemic situations, need to be carefully managed during the pre-operative, peri-operative and postoperative phases through a synergistic collaboration among different kind of specialists.

Entities:  

Keywords:  CTX; bisphosphonate osteonecrosis; oral surgery; therapeutic approach

Year:  2012        PMID: 23285320      PMCID: PMC3512552     

Source DB:  PubMed          Journal:  Ann Stomatol (Roma)        ISSN: 1824-0852


  13 in total

1.  Severe oral ulcerations induced by alendronate.

Authors:  N Demerjian; G Bolla; A Spreux
Journal:  Clin Rheumatol       Date:  1999       Impact factor: 2.980

2.  Compromised osseous healing of dental extraction sites in zoledronic acid-treated dogs.

Authors:  M R Allen; D J Kubek; D B Burr; S L Ruggiero; T-M G Chu
Journal:  Osteoporos Int       Date:  2010-05-11       Impact factor: 4.507

Review 3.  Technological characteristics and clinical indications of piezoelectric bone surgery.

Authors:  T Vercellotti
Journal:  Minerva Stomatol       Date:  2004-05

4.  American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws.

Authors: 
Journal:  J Oral Maxillofac Surg       Date:  2007-03       Impact factor: 1.895

Review 5.  [The bisphosponates: chemical characteristics, skeletal biological effects and extra-skeletal effects].

Authors:  A Corrado; F P Cantatore
Journal:  Reumatismo       Date:  2005 Jul-Sep

6.  Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.

Authors:  Robert E Marx; Yoh Sawatari; Michel Fortin; Vishtasb Broumand
Journal:  J Oral Maxillofac Surg       Date:  2005-11       Impact factor: 1.895

7.  Alendronate-related oral mucosa ulcerations.

Authors:  M A Gonzalez-Moles; J V Bagan-Sebastian
Journal:  J Oral Pathol Med       Date:  2000-11       Impact factor: 4.253

Review 8.  Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws.

Authors:  Sook-Bin Woo; John W Hellstein; John R Kalmar
Journal:  Ann Intern Med       Date:  2006-05-16       Impact factor: 25.391

9.  Intravenous bisphosphonate-associated osteonecrosis of the jaw.

Authors:  Thomas A Statz; Janet M Guthmiller; Lewis A Humbert; Georgia K Johnson
Journal:  J Periodontol       Date:  2007-11       Impact factor: 6.993

10.  Reconstruction of defects caused by bisphosphonate-induced osteonecrosis of the jaws.

Authors:  Robert E Marx
Journal:  J Oral Maxillofac Surg       Date:  2009-05       Impact factor: 1.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.